GLP-1R Agonist Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: G39397338BFBEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of GLP-1R Agonist in Global, including the following market information:

Global GLP-1R Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global GLP-1R Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Exenatide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of GLP-1R Agonist include GSK, Novo Nordisk, Lily, Haosoh, Sanofi and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GLP-1R Agonist companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global GLP-1R Agonist Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global GLP-1R Agonist Market Segment Percentages, by Type, 2021 (%)

• Exenatide
• Liraglutide
• Lixisenatide
• Albiglutide
• Others

Global GLP-1R Agonist Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global GLP-1R Agonist Market Segment Percentages, by Application, 2021 (%)

• Solid Tumors
• Blood-related Tumors

Global GLP-1R Agonist Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global GLP-1R Agonist Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies GLP-1R Agonist revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies GLP-1R Agonist revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Novo Nordisk
• Lily
• Haosoh
• Sanofi
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 GLP-1R Agonist Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global GLP-1R Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLP-1R AGONIST OVERALL MARKET SIZE

2.1 Global GLP-1R Agonist Market Size: 2021 VS 2028
2.2 Global GLP-1R Agonist Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top GLP-1R Agonist Players in Global Market
3.2 Top Global GLP-1R Agonist Companies Ranked by Revenue
3.3 Global GLP-1R Agonist Revenue by Companies
3.4 Top 3 and Top 5 GLP-1R Agonist Companies in Global Market, by Revenue in 2021
3.5 Global Companies GLP-1R Agonist Product Type
3.6 Tier 1, Tier 2 and Tier 3 GLP-1R Agonist Players in Global Market
  3.6.1 List of Global Tier 1 GLP-1R Agonist Companies
  3.6.2 List of Global Tier 2 and Tier 3 GLP-1R Agonist Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global GLP-1R Agonist Market Size Markets, 2021 & 2028
  4.1.2 Exenatide
  4.1.3 Liraglutide
  4.1.4 Lixisenatide
  4.1.5 Albiglutide
  4.1.6 Others
4.2 By Type - Global GLP-1R Agonist Revenue & Forecasts
  4.2.1 By Type - Global GLP-1R Agonist Revenue, 2017-2022
  4.2.2 By Type - Global GLP-1R Agonist Revenue, 2023-2028
  4.2.3 By Type - Global GLP-1R Agonist Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global GLP-1R Agonist Market Size, 2021 & 2028
  5.1.2 Solid Tumors
  5.1.3 Blood-related Tumors
5.2 By Application - Global GLP-1R Agonist Revenue & Forecasts
  5.2.1 By Application - Global GLP-1R Agonist Revenue, 2017-2022
  5.2.2 By Application - Global GLP-1R Agonist Revenue, 2023-2028
  5.2.3 By Application - Global GLP-1R Agonist Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global GLP-1R Agonist Market Size, 2021 & 2028
6.2 By Region - Global GLP-1R Agonist Revenue & Forecasts
  6.2.1 By Region - Global GLP-1R Agonist Revenue, 2017-2022
  6.2.2 By Region - Global GLP-1R Agonist Revenue, 2023-2028
  6.2.3 By Region - Global GLP-1R Agonist Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America GLP-1R Agonist Revenue, 2017-2028
  6.3.2 US GLP-1R Agonist Market Size, 2017-2028
  6.3.3 Canada GLP-1R Agonist Market Size, 2017-2028
  6.3.4 Mexico GLP-1R Agonist Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe GLP-1R Agonist Revenue, 2017-2028
  6.4.2 Germany GLP-1R Agonist Market Size, 2017-2028
  6.4.3 France GLP-1R Agonist Market Size, 2017-2028
  6.4.4 U.K. GLP-1R Agonist Market Size, 2017-2028
  6.4.5 Italy GLP-1R Agonist Market Size, 2017-2028
  6.4.6 Russia GLP-1R Agonist Market Size, 2017-2028
  6.4.7 Nordic Countries GLP-1R Agonist Market Size, 2017-2028
  6.4.8 Benelux GLP-1R Agonist Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia GLP-1R Agonist Revenue, 2017-2028
  6.5.2 China GLP-1R Agonist Market Size, 2017-2028
  6.5.3 Japan GLP-1R Agonist Market Size, 2017-2028
  6.5.4 South Korea GLP-1R Agonist Market Size, 2017-2028
  6.5.5 Southeast Asia GLP-1R Agonist Market Size, 2017-2028
  6.5.6 India GLP-1R Agonist Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America GLP-1R Agonist Revenue, 2017-2028
  6.6.2 Brazil GLP-1R Agonist Market Size, 2017-2028
  6.6.3 Argentina GLP-1R Agonist Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa GLP-1R Agonist Revenue, 2017-2028
  6.7.2 Turkey GLP-1R Agonist Market Size, 2017-2028
  6.7.3 Israel GLP-1R Agonist Market Size, 2017-2028
  6.7.4 Saudi Arabia GLP-1R Agonist Market Size, 2017-2028
  6.7.5 UAE GLP-1R Agonist Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK GLP-1R Agonist Major Product Offerings
  7.1.4 GSK GLP-1R Agonist Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk GLP-1R Agonist Major Product Offerings
  7.2.4 Novo Nordisk GLP-1R Agonist Revenue in Global Market (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Lily
  7.3.1 Lily Corporate Summary
  7.3.2 Lily Business Overview
  7.3.3 Lily GLP-1R Agonist Major Product Offerings
  7.3.4 Lily GLP-1R Agonist Revenue in Global Market (2017-2022)
  7.3.5 Lily Key News
7.4 Haosoh
  7.4.1 Haosoh Corporate Summary
  7.4.2 Haosoh Business Overview
  7.4.3 Haosoh GLP-1R Agonist Major Product Offerings
  7.4.4 Haosoh GLP-1R Agonist Revenue in Global Market (2017-2022)
  7.4.5 Haosoh Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi GLP-1R Agonist Major Product Offerings
  7.5.4 Sanofi GLP-1R Agonist Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca GLP-1R Agonist Major Product Offerings
  7.6.4 AstraZeneca GLP-1R Agonist Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. GLP-1R Agonist Market Opportunities & Trends in Global Market
Table 2. GLP-1R Agonist Market Drivers in Global Market
Table 3. GLP-1R Agonist Market Restraints in Global Market
Table 4. Key Players of GLP-1R Agonist in Global Market
Table 5. Top GLP-1R Agonist Players in Global Market, Ranking by Revenue (2021)
Table 6. Global GLP-1R Agonist Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global GLP-1R Agonist Revenue Share by Companies, 2017-2022
Table 8. Global Companies GLP-1R Agonist Product Type
Table 9. List of Global Tier 1 GLP-1R Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GLP-1R Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global GLP-1R Agonist Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - GLP-1R Agonist Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - GLP-1R Agonist Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global GLP-1R Agonist Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - GLP-1R Agonist Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - GLP-1R Agonist Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global GLP-1R Agonist Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global GLP-1R Agonist Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global GLP-1R Agonist Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America GLP-1R Agonist Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America GLP-1R Agonist Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe GLP-1R Agonist Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe GLP-1R Agonist Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia GLP-1R Agonist Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia GLP-1R Agonist Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America GLP-1R Agonist Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America GLP-1R Agonist Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa GLP-1R Agonist Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa GLP-1R Agonist Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK GLP-1R Agonist Product Offerings
Table 32. GSK GLP-1R Agonist Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk GLP-1R Agonist Product Offerings
Table 35. Novo Nordisk GLP-1R Agonist Revenue (US$, Mn), (2017-2022)
Table 36. Lily Corporate Summary
Table 37. Lily GLP-1R Agonist Product Offerings
Table 38. Lily GLP-1R Agonist Revenue (US$, Mn), (2017-2022)
Table 39. Haosoh Corporate Summary
Table 40. Haosoh GLP-1R Agonist Product Offerings
Table 41. Haosoh GLP-1R Agonist Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi GLP-1R Agonist Product Offerings
Table 44. Sanofi GLP-1R Agonist Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca GLP-1R Agonist Product Offerings
Table 47. AstraZeneca GLP-1R Agonist Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. GLP-1R Agonist Segment by Type in 2021
Figure 2. GLP-1R Agonist Segment by Application in 2021
Figure 3. Global GLP-1R Agonist Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global GLP-1R Agonist Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global GLP-1R Agonist Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by GLP-1R Agonist Revenue in 2021
Figure 8. By Type - Global GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 9. By Application - Global GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 10. By Region - Global GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 11. By Country - North America GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 12. US GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 13. Canada GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 16. Germany GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 17. France GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 19. Italy GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 20. Russia GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 24. China GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 25. Japan GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 28. India GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 30. Brazil GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa GLP-1R Agonist Revenue Market Share, 2017-2028
Figure 33. Turkey GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 34. Israel GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 36. UAE GLP-1R Agonist Revenue, (US$, Mn), 2017-2028
Figure 37. GSK GLP-1R Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk GLP-1R Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lily GLP-1R Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Haosoh GLP-1R Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi GLP-1R Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca GLP-1R Agonist Revenue Year Over Year Growth (US$, Mn) & (2017-2022)